Książki na temat „EXtremely Drug Resistant Tuberculosis”

National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of Tuberculosis Elimination. TB elimination: Treatment of drug-resistant tuberculosis. Atlanta, Ga.]: National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Division of Tuberculosis Elimination, 2012.

Harvard Medical School. Program in Infectious Disease and Social Change. i Open Society Institute, red. The global impact of drug-resistant tuberculosis. Boston, MA: Program in Infectious Disease and Social Change, Dept. of Social Medicine, Harvard Medical School, 1999.

Nguy, Shui. Drug-resistant tuberculosis: Causes, diagnosis, and treatments. Redaktor K'ung Zhou. Hauppauge NY: Nova Science Publishers, 2009.

Crofton, John. Guidelines for the management of drug-resistant tuberculosis. Geneva: World Health Organization, 1997.

Crofton, John Wenman. Guidelines for the management of drug-resistant tuberculosis. Geneva: World Health Organization, 1997.

John, Crofton. Guidelines for the management of drug-resistant tuberculosis. Geneva: WHO, 1997.

John, Crofton. Guidelines for the management of drug-resistant tuberculosis. Geneva: World Health Organization, 1997.

Guidelines on the management of drug-resistant tuberculosis. [Geneva]: World Health Organization, 1997.

N, Rom William, i Garay Stuart M, red. Tuberculosis. Boston: Little, Brown, 1996.

Michael, Rich, i World Health Organization, red. Guidelines for the programmatic management of drug-resistant tuberculosis. Geneva: World Health Organization, 2006.

Hopkins, Tanne Janice, red. Timebomb: The global epidemic of multi-drug-resistant tuberculosis. New York: McGraw-Hill, 2002.

Vinšová, Jarmila. Development of new MDR-tuberculosis drugs. Hauppauge, N.Y: Nova Science Publisher, 2010.

Wiegandt, Axel. Framework to address multi-drug-resistant TB in the Pacific island countries and territories. Noumea, New Caledonia: Secretariat of the Pacific community, 2010.

Nurses, International Council of. TB guidelines: For nurses in the care and control of tuberculosis and multi-drug resistant tuberculosis. Geneva, Switzerland: International Council of Nurses, 2004.

Ernesto, Jaramillo, Stop TB Initiative (World Health Organization), Great Britain. Dept. for International Development. i United States. Agency for International Development., red. Guidelines for the programmatic management of drug-resistant tuberculosis: [emergency update 2008]. Geneva: World Health Organization, Stop TB Department, 2008.

Ernesto, Jaramillo, Stop TB Initiative (World Health Organization), Great Britain. Dept. for International Development. i United States. Agency for International Development., red. Guidelines for the programmatic management of drug-resistant tuberculosis: [emergency update 2008]. Geneva: World Health Organization, Stop TB Department, 2008.

Falzon, Dennis. Guidelines for surveillance of drug resistance in tuberculosis. Wyd. 4. Geneva: World Health Organization, 2009.

Matteo, Zignol, i WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance., red. Anti-tuberculosis drug resistance in the world: Fourth global report : the World Health Organization/International Union Against Tuberculosis and Lung Disease (WHO/UNION) Global Project on Anti-Tuberculosis Drug Resistance Surveillance, 2002-2007. Geneva, Switzerland: World Health Organization, 2008.

Wright, Abigail. Anti-tuberculosis drug resistance in the world: Fourth global report : the World Health Organization/International Union Against Tuberculosis and Lung Disease (WHO/UNION) Global Project on Anti-Tuberculosis Drug Resistance Surveillance, 2002-2007. Geneva, Switzerland: World Health Organization, 2008.

Institute of Medicine (U.S.). Forum on Drug Discovery, Development, and Translation, red. Addressing the threat of drug-resistant tuberculosis: A realistic assessment of the challenge : workshop summary. Washington, D.C: National Academies Press, 2009.

Parliamentary Office of Science and Technology. Diseases fighting back. London: Parliamentary Office of Science and Technology, 1994.

Protecting the United States from drug-resistant tuberculosis: Reinvesting in control and new tools research : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Tenth Congress, first session, on examining ways to protect the United States from the rising threat of drug-resistant tuberculosis, focusing on reinvesting in control and new tools research, October 30, 2007. Washington: U.S. G.P.O., 2009.

United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions. Protecting the United States from drug-resistant tuberculosis: Reinvesting in control and new tools research : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Tenth Congress, first session, on examining ways to protect the United States from the rising threat of drug-resistant tuberculosis, focusing on reinvesting in control and new tools research, October 30, 2007. Washington: U.S. G.P.O., 2009.

N, Rom William, i Garay Stuart M, red. Tuberculosis. Wyd. 2. Philadelphia: Lippincott Williams & Wilkins, 2004.

author, Wilker Ian, i Ambrose Marylou author, red. Tuberculosis and superbugs: Examining TB and bacterial infections. Berkeley Heights, NJ: Jasmine Health, 2014.

Kelly, Evelyn B. Investigating tuberculosis and superbugs: Real facts for real lives. Berkeley Heights, NJ: Enslow Publishers, 2011.

Institute of Medicine (U.S.). Forum on Drug Discovery, Development, and Translation i Rossiĭskai︠a︡ akademii︠a︡ medit︠s︡inskikh nauk, red. The new profile of drug-resistant tuberculosis in Russia: A global and local perspective : summary of a joint workshop by the Institute of Medicine and the Russian Academy of Medical Science. Washington, D.C: National Academies Press, 2011.

World Health Organization (WHO). Management of MDR-TB: A field guide, a companion document to Guidelines for the programmatic management of drug-resistant tuberculosis. Geneva: World Health Organization, 2009.

I, Skarlatos Sonia, Velletri Paul August, Morris Mariana 1947-, Davies P. D. O i New York Academy of Sciences., red. New vistas in therapeutics: From drug design to gene therapy. New York, N.Y: New York Academy of Sciences, 2001.

Border, Peter. Diseases fighting back: The growing resistance of TB and other bacterial diseases to treatment. London: Parliamentary Office of Science and Technology, 1994.

LaScolea, Len J. Quinolones in pulmonary tuberculosis management. Frankfurt, Germany: Hoechst, 1996.

Tom, Frieden, i World Health Organization, red. Toman's tuberculosis: Case detection, treatment, and monitoring : questions and answers. Wyd. 2. Geneva: World Health Organization, 2004.

World Health Organization (WHO). Global tuberculosis control: WHO report 2010. Geneva: World Health Organization, 2010.

Ian, Wilker, i Ambrose Marylou, red. Investigating tuberculosis and superbugs: Real facts for real lives. Berkeley Heights, NJ: Enslow Publishers, 2011.

Multi-drug resistant tuberculosis: Assessing the U.S. response to an emerging global threat : hearing before the Subcommittee on Africa and Global Health of the Committee on Foreign Affairs, House of Representatives, One Hundred Tenth Congress, second session, February 27, 2008. Washington: U.S. G.P.O., 2008.

Zumla, Alimuddin, David S. C. Hui i Wing-Wai Yew. Emerging respiratory infections in the 21st century. Philadelphia, PA: Saunders, 2010.

The global threat of drug-resistant TB: A call to action for World TB Day : briefing and hearing before the Subcommittee on Africa and Global Health of the Committee on Foreign Affairs, House of Representatives, One Hundred Tenth Congress, first session, March 21, 2007. Washington: U.S. G.P.O., 2007.

Laniado-Laborín, Rafael, red. Drug Resistant Tuberculosis. BENTHAM SCIENCE PUBLISHERS, 2015. http://dx.doi.org/10.2174/97816810806661150101.

Pasca, Maria Rosalia, Yossef Av-Gay i Giorgia Mori, red. New Approaches Against Drug-Resistant M. tuberculosis. Frontiers Media SA, 2021. http://dx.doi.org/10.3389/978-2-88966-869-4.

Addressing the Threat of Drug-Resistant Tuberculosis. Washington, D.C.: National Academies Press, 2009. http://dx.doi.org/10.17226/12570.

Facing the Reality of Drug-Resistant Tuberculosis. Washington, D.C.: National Academies Press, 2012. http://dx.doi.org/10.17226/13243.

Timebomb : The Global Epidemic of Multi-Drug Resistant Tuberculosis. McGraw-Hill, 2003.

World Health Organization (WHO). Guidelines for the Management of Drug-resistant Tuberculosis. World Health Organization, 1997.

Laborin, Rafael Laniado. Drug Resistant Tuberculosis: Practical guide for clinical management. Bentham Science Publishers, 2018.

Reichman, Lee B., i Janice Hopkins Tanne. Timebomb:The Global Epidemic of Multi-Drug Resistant Tuberculosis. McGraw-Hill Companies, 2001.

Reichman, Lee B., i Janice Hopkins Tanne. Timebomb:The Global Epidemic of Multi-Drug Resistant Tuberculosis. McGraw-Hill Companies, 2001.

World Health Organization (WHO). Guidelines for the Management of Drug-resistant Tuberculosis. World Health Organization, 1997.

Davies, P. D. O. Drug-Resistant Tuberculosis: From Molecules to Macro-Economics. New York Academy of Sciences, 2002.

Prevalence and Factors Associated with Multidrug/rifampicin Resistant Tuberculosis among Suspected Drug Resistant Tuberculosis Patients in Botswana. Independently Published, 2020.

The New Profile of Drug-Resistant Tuberculosis in Russia. Washington, D.C.: National Academies Press, 2011. http://dx.doi.org/10.17226/13033.